BioAge Labs announced that the company has made the decision to discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag as monotherapy and in combination with tirzepatide after liver transaminitis without clinically significant symptoms was observed in some subjects receiving azelaprag
Whether you are focused on healthy aging, energy, or hair vitality, we are here to provide the high-trust, science-forward tools you need to feel your best
From the manufacturing perspective, this level of international reach usually indicates that a company has already developed systems capable of handling export documentation, regulatory standards, and cross-border logistics
Do you need a sharps container for Ozempic
This preoccupation has multiple drivers
The honest conversation we need is around safety standards: if patients are going to do this anyway, what is the minimum guidance we should provide